NTRK2 and Huntington disease: More importantly, this discovery holds significance for HD treatment as inhibiting ADAM10 can prevent two critical molecular dysfunctions in the HD synapse: synaptic cell adhesion defects [18] and downregulation of the BDNF/TrkB pathway [14].